{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:14:36Z","timestamp":1792084476281,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,23]]},"DOI":"10.7759\/cureus.60962","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T06:00:31Z","timestamp":1716530431000},"source":"Crossref","is-referenced-by-count":5,"title":["Integrated Approaches in the Management of Gastrointestinal Disorders: A Biopsychosocial Perspective"],"prefix":"10.7759","author":[{"given":"Muhammad Aamir","family":"Chughtai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munara  K","family":"Kerimkulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhavari","family":"Hagenahalli Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Shehryar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzafar","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehryar","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018","volume":"156","author":"Peery AF","year":"2019","unstructured":"Peery AF, Crockett SD, Murphy CC, et al.. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterol. 2019, 156:254-72.e11. 10.1053\/j.gastro.2018.08.063","journal-title":"Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2013.11.006","article-title":"Epidemiology of gastroesophageal reflux disease","volume":"43","author":"Rubenstein JH","year":"2014","unstructured":"Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014, 43:1-14. 10.1016\/j.gtc.2013.11.006","journal-title":"Gastroenterol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas PJ","year":"2008","unstructured":"Kahrilas PJ, Shaheen NJ, Vaezi MF, et al.. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterol. 2008, 135:1383-91, 1391.e1-5. 10.1053\/j.gastro.2008.08.045","journal-title":"Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1753465810384606","article-title":"The relationship between gastroesophageal reflux and asthma: an update","volume":"5","author":"McCallister JW","year":"2011","unstructured":"McCallister JW, Parsons JP, Mastronarde JG. The relationship between gastroesophageal reflux and asthma: an update. Ther Adv Respir Dis. 2011, 5:143-50. 10.1177\/1753465810384606","journal-title":"Ther Adv Respir Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz PO","year":"2013","unstructured":"Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013, 108:308-28; quiz 329. 10.1038\/ajg.2012.444","journal-title":"Am J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/140.5.1294","article-title":"Chronic cough as the sole presenting manifestation of gastroesophageal reflux","volume":"140","author":"Irwin RS","year":"1989","unstructured":"Irwin RS, Zawacki JK, Curley FJ, French CL, Hoffman PJ. Chronic cough as the sole presenting manifestation of gastroesophageal reflux. Am Rev Respir Dis. 1989, 140:1294-300. 10.1164\/ajrccm\/140.5.1294","journal-title":"Am Rev Respir Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-014-4008-6","article-title":"Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6\u00a0years: a prospective single-center study","volume":"29","author":"Testoni PA","year":"2015","unstructured":"Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6\u00a0years: a prospective single-center study. Surg Endosc. 2015, 29:2770-80. 10.1007\/s00464-014-4008-6","journal-title":"Surg Endosc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20560","article-title":"Inflammatory bowel disease: the difference between children and adults","volume":"14 Suppl 2","author":"Kelsen J","year":"2008","unstructured":"Kelsen J, Baldassano RN. Inflammatory bowel disease: the difference between children and adults. Inflamm Bowel Dis. 2008, 14 Suppl 2:S9-11. 10.1002\/ibd.20560","journal-title":"Inflamm Bowel Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-012-0302-4","article-title":"Environmental triggers for inflammatory bowel disease","volume":"15","author":"Ananthakrishnan AN","year":"2013","unstructured":"Ananthakrishnan AN. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep. 2013, 15:302. 10.1007\/s11894-012-0302-4","journal-title":"Curr Gastroenterol Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10060367","article-title":"Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults","volume":"10","author":"Krzystek-Korpacka M","year":"2020","unstructured":"Krzystek-Korpacka M, Kempi\u0144ski R, Bromke M, Neubauer K. Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults. Diagnostics (Basel). 2020, 10:367. 10.3390\/diagnostics10060367","journal-title":"Diagnostics (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein GR","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018, 113:481-517. 10.1038\/ajg.2018.27","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22636","article-title":"Ulcerative colitis-induced colorectal carcinoma: a deleterious concatenation","volume":"14","author":"Rivera AP","year":"2022","unstructured":"Rivera AP, Flores Monar GV, Islam H, et al.. Ulcerative colitis-induced colorectal carcinoma: a deleterious concatenation. Cureus. 2022, 14:e22636. 10.7759\/cureus.22636","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833424","article-title":"Helicobacter pylori and autoimmune diseases: involving multiple systems","volume":"13","author":"Wang L","year":"2022","unstructured":"Wang L, Cao ZM, Zhang LL, et al.. Helicobacter pylori and autoimmune diseases: involving multiple systems. Front Immunol. 2022, 13:833424. 10.3389\/fimmu.2022.833424","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2015.1019918","article-title":"Chronic gastritis","volume":"50","author":"Sipponen P","year":"2015","unstructured":"Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015, 50:657-67. 10.3109\/00365521.2015.1019918","journal-title":"Scand J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-002-0053-7","article-title":"Pharmacologic management of gastroesophageal reflux disease","volume":"5","author":"Ramakrishnan A","year":"2002","unstructured":"Ramakrishnan A, Katz PO. Pharmacologic management of gastroesophageal reflux disease. Curr Treat Options Gastroenterol. 2002, 5:301-10. 10.1007\/s11938-002-0053-7","journal-title":"Curr Treat Options Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000182103.32504.e3","article-title":"Effects of probiotics on the gastrointestinal tract","volume":"18","author":"Snelling AM","year":"2005","unstructured":"Snelling AM. Effects of probiotics on the gastrointestinal tract. Curr Opin Infect Dis. 2005, 18:420-6. 10.1097\/01.qco.0000182103.32504.e3","journal-title":"Curr Opin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1113994","article-title":"Clinical practice. Celiac disease","volume":"367","author":"Fasano A","year":"2012","unstructured":"Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med. 2012, 367:2419-26. 10.1056\/NEJMcp1113994","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl B","year":"2018","unstructured":"Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018, 391:70-81. 10.1016\/S0140-6736(17)31796-8","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22912","article-title":"Association between type 1 diabetes mellitus and celiac disease: autoimmune disorders with a shared genetic background","volume":"14","author":"Flores Monar GV","year":"2022","unstructured":"Flores Monar GV, Islam H, Puttagunta SM, et al.. Association between type 1 diabetes mellitus and celiac disease: autoimmune disorders with a shared genetic background. Cureus. 2022, 14:e22912. 10.7759\/cureus.22912","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.09.032","article-title":"Gluten introduction to infant feeding and risk of celiac disease: systematic review and meta-analysis","volume":"168","author":"Pinto-S\u00e1nchez MI","year":"2016","unstructured":"Pinto-S\u00e1nchez MI, Verdu EF, Liu E, et al.. Gluten introduction to infant feeding and risk of celiac disease: systematic review and meta-analysis. J Pediatr. 2016, 168:132-43.e3. 10.1016\/j.jpeds.2015.09.032","journal-title":"J Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel G","year":"2017","unstructured":"Goel G, King T, Daveson AJ, et al.. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol Hepatol. 2017, 2:479-93. 10.1016\/S2468-1253(17)30110-3","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2153103","article-title":"Effect of a gluten-free diet on bone mineral density in children and adolescents with celiac disease: systematic review and meta-analysis","author":"Oliveira DD","year":"2022","unstructured":"Oliveira DD, da Silva DC, Kawano MM, de Castro CT, Pereira M. Effect of a gluten-free diet on bone mineral density in children and adolescents with celiac disease: systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2022, 1-11. 10.1080\/10408398.2022.2153103","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2010.01664.x","article-title":"The microbiome-gut-brain axis: from bowel to behavior","volume":"23","author":"Cryan JF","year":"2011","unstructured":"Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil. 2011, 23:187-92. 10.1111\/j.1365-2982.2010.01664.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12308","article-title":"Defining dysbiosis and its influence on host immunity and disease","volume":"16","author":"Petersen C","year":"2014","unstructured":"Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014, 16:1024-33. 10.1111\/cmi.12308","journal-title":"Cell Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S27530","article-title":"Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease","volume":"7","author":"Ghouri YA","year":"2014","unstructured":"Ghouri YA, Richards DM, Rahimi EF, Krill JT, Jelinek KA, DuPont AW. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol. 2014, 7:473-87. 10.2147\/CEG.S27530","journal-title":"Clin Exp Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases","volume":"94","author":"Ramos GP","year":"2019","unstructured":"Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019, 94:155-65. 10.1016\/j.mayocp.2018.09.013","journal-title":"Mayo Clin Proc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman JM","year":"2015","unstructured":"Norman JM, Handley SA, Baldridge MT, et al.. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015, 160:447-60. 10.1016\/j.cell.2015.01.002","journal-title":"Cell"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00104-015-0085-x","article-title":"[Management of complications in endoscopic interventions of the upper gastrointestinal tract]","volume":"86","author":"Dittmar Y","year":"2015","unstructured":"Dittmar Y, Rauchfuss F, Settmacher U. [Management of complications in endoscopic interventions of the upper gastrointestinal tract]. Chirurg. 2015, 86:1007-13. 10.1007\/s00104-015-0085-x","journal-title":"Chirurg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1039\/c3lc50169h","article-title":"Paper-based microfluidic point-of-care diagnostic devices","volume":"13","author":"Yetisen AK","year":"2013","unstructured":"Yetisen AK, Akram MS, Lowe CR. Paper-based microfluidic point-of-care diagnostic devices. Lab Chip. 2013, 13:2210-51. 10.1039\/c3lc50169h","journal-title":"Lab Chip"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"B\u00e4ckhed F","year":"2005","unstructured":"B\u00e4ckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005, 307:1915-20. 10.1126\/science.1104816","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"Chey WD","year":"2015","unstructured":"Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. J Am Med Assoc. 2015, 313:949-58. 10.1001\/jama.2015.0954","journal-title":"J Am Med Assoc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i24.7570","article-title":"Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome","volume":"20","author":"Muscatello MR","year":"2014","unstructured":"Muscatello MR, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol. 2014, 20:7570-86. 10.3748\/wjg.v20.i24.7570","journal-title":"World J Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168870","article-title":"The gut-brain axis in inflammatory bowel disease-current and future perspectives","volume":"22","author":"G\u00fcnther C","year":"2021","unstructured":"G\u00fcnther C, Rothhammer V, Karow M, Neurath M, Winner B. The gut-brain axis in inflammatory bowel disease-current and future perspectives. Int J Mol Sci. 2021, 22:8870. 10.3390\/ijms22168870","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/249839-integrated-approaches-in-the-management-of-gastrointestinal-disorders-a-biopsychosocial-perspective","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T06:00:37Z","timestamp":1716530437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/249839-integrated-approaches-in-the-management-of-gastrointestinal-disorders-a-biopsychosocial-perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.60962","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}